We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 1,309 results
  1. Antifungal Susceptibility of Yeasts and Filamentous Fungi by CLSI Broth Microdilution Testing

    Antifungal susceptibility testing is performed against yeasts and filamentous fungi (molds) for various purposes. In clinical settings, the results...
    Nathan P. Wiederhold in Antifungal Drug Resistance
    Protocol 2023
  2. Antifungal Susceptibility Testing and Drug Discovery in the Dimorphic Fungus Histoplasma Capsulatum

    The thermal dimorphism of the fungal pathogen Histoplasma is linked to its virulence in mammalian hosts. Mammalian body temperature triggers...
    Chad A. Rappleye in Antifungal Drug Resistance
    Protocol 2023
  3. Antifungal Susceptibility Testing of Dermatophytes

    In order to help guide treatment, antifungal susceptibility testing is often performed in clinical microbiology laboratories. The results of these in...
    Nathan P. Wiederhold in Dermatophytes and Dermatophytoses
    Chapter 2021
  4. New Antifungal Drugs: Discovery and Therapeutic Potential

    There has been an increase in invasive fungal infections, which are a universal problem due to the longer average lifespan, the number of...
    Francisca Vicente, Fernando Reyes, Olga Genilloud in Fungi Bioactive Metabolites
    Chapter 2024
  5. Emerging Antifungal Resistance in Fungal Pathogens

    Purpose of Review

    Over recent decades, the number of outbreaks caused by fungi has increased for humans, plants (including important crop species) and...

    Sui Ting Hui, Hugh Gifford, Johanna Rhodes in Current Clinical Microbiology Reports
    Article Open access 18 March 2024
  6. The Metabolism of Susceptibility: Clearing the FoG Between Tolerance and Resistance in Candida albicans

    Purpose of Review

    Failure of antifungal treatment is alarmingly common in patients infected with Candida albicans isolates that test as susceptible...

    Marina Druseikis, Austin Mottola, Judith Berman in Current Clinical Microbiology Reports
    Article 28 March 2023
  7. Heterologous Expression of Candida Antifungal Target Genes in the Model Organism Saccharomyces cerevisiae

    Understanding how a gene variant may influence antifungal resistance, or other phenotypic characteristics, is an important step in determining or...
    Kelley R. Healey, Ashutosh Singh in Antifungal Drug Resistance
    Protocol 2023
  8. Luciferase-Based High-Throughput Screen with Aspergillus fumigatus to Identify Antifungal Small Molecules

    Only three classes of contemporary antifungal drugs are routinely utilized in the clinic against filamentous fungal pathogens such as Aspergillus...
    Timothy J. Opperman, Sourabh Dhingra, ... Robert A. Cramer in Antifungal Drug Resistance
    Protocol 2023
  9. Pulmonary surfactant impacts in vitro activity of selected antifungal drugs against Candida krusei and Candida albicans

    Purpose

    This study investigates how surfactants affect the in-vitro anti-infective efficacy of micafungin, caspofungin, anidulafungin, and...

    Alina Nussbaumer-Pröll, Peter Matzneller, ... Markus Zeitlinger in European Journal of Clinical Microbiology & Infectious Diseases
    Article Open access 14 March 2024
  10. Comparison of in vitro activities of newer triazoles and classic antifungal agents against dermatophyte species isolated from Iranian University Hospitals: a multi-central study

    Background

    Dermatophytes have the ability to invade the keratin layer of humans and cause infections. The aims of this study were the accurate...

    Parisa Badiee, Tahereh Shokohi, ... Hadis Jafarian in Annals of Clinical Microbiology and Antimicrobials
    Article Open access 20 February 2023
  11. Antibacterial, antifungal activities and toxicity of new synthetic fatty acid salicylate esters

    Microbial threats and their resistance to the available drugs are public health concerns that scientists worldwide are trying to solve. Before the...

    Monique B. Ewonkem, Pascaline M. Deussom, ... Duplex J. Wansi in Medicinal Chemistry Research
    Article 20 February 2023
  12. When to Initiate Antifungal Treatment in COVID-19 Patients with Secondary Fungal Co-infection

    Purpose of Review

    Severe-acute respiratory coronavirus 2 (SARS-CoV-2) has been driving the health care delivery system for over 2 years. With time,...

    Harnoor Singh Pruthi in Current Clinical Microbiology Reports
    Article 03 November 2022
  13. A longitudinal study of Candida bloodstream infections in a Japanese university hospital: species distribution, drug susceptibility, clinical features, and mortality predictors

    We aimed to detect possible changes in Candida species distribution over time and to know the antifungal susceptibility profile of isolates obtained...

    Hitoshi Tsukamoto, Takashi Higashi, ... Nobuyuki Goto in European Journal of Clinical Microbiology & Infectious Diseases
    Article 26 September 2022
  14. Exploiting response surface D-optimal design study for preparation and optimization of spanlastics loaded with miconazole nitrate as a model antifungal drug for topical application

    Purpose

    Skin fungal infections are widely spreading worldwide and are considered a main cause of skin, mucous membranes, and systemic diseases. In an...

    Mervat Shafik Ibrahim, Omar A. Elkady, ... Shereen H. Noshi in Journal of Pharmaceutical Innovation
    Article Open access 30 November 2023
  15. Population differentiation, antifungal susceptibility, and host range of Trichophyton mentagrophytes isolates causing recalcitrant infections in humans and animals

    The major problems in determining the causative factors of the high prevalence of dermatophytoses include the lack of a well-standardized antifungal...

    Sebastian Gnat, Dominik Łagowski, ... Łukasz Kopiński in European Journal of Clinical Microbiology & Infectious Diseases
    Article Open access 30 June 2020
  16. A Simple Antifungal assay for Testing Actinomycetes and Other Microbial Extracts

    Antifungal assay in vitro is a useful tool for the characterization of biological activity of microbial extracts. Here we describe a simple in vitro...
    María A. Vinuesa, Antonio Fernández in Antimicrobial Therapies
    Protocol 2021
  17. Change in species distribution and antifungal susceptibility of candidemias in an intensive care unit of a university hospital (10-year experience)

    Candidemia is a nosocomial infection mostly found in critically ill patients. Our objectives were to evaluate the change in distribution and...

    Bilgul Mete, Esra Yerlikaya Zerdali, ... Recep Ozturk in European Journal of Clinical Microbiology & Infectious Diseases
    Article 15 September 2020
  18. Antifungal Drugs: Mechanism of Action and Resistance

    Overuse of antifungal drugs in recent years has developed resistance against these drugs. The significant clinical influence of resistance has...
    Muhammad Zeeshan Ahmed, Tazeen Rao, ... Sarfraz Ahmed in Biochemistry of Drug Resistance
    Chapter 2021
  19. New Antifungal Agents and New Formulations Against Dermatophytes

    There are a plethora of antifungal agents available for the treatment of onychomycosis. Systemic antifungal drugs are generally recommended for...
    Aditya K. Gupta, Maanasa Venkataraman, Emma M. Quinlan in Dermatophytes and Dermatophytoses
    Chapter 2021
  20. Deletion of both Dectin-1 and Dectin-2 affects the bacterial but not fungal gut microbiota and susceptibility to colitis in mice

    Background

    Innate immunity genes have been reported to affect susceptibility to inflammatory bowel diseases (IBDs) and colitis in mice. Dectin-1, a...

    Yazhou Wang, Madeleine Spatz, ... Mathias L. Richard in Microbiome
    Article Open access 14 June 2022
Did you find what you were looking for? Share feedback.